E-DRUG Archives (by thread)

Date Index

[e-drug] Update your WHO/EDM Bookshelf, Hans Hogerzeil

[e-drug] rofecoxib ban in India (6), Eurek Ranjit

[e-drug] MSF: Lack of AIDS Drugs for Children a Matter of Life and Death, Sean . HEALY

[e-drug] Cost/efficient procurement (2), Oliver Hazemba

[e-drug] Paediatric AIDS is a neglected disease, Sean Healy

[e-drug] Teaching pharmacy and medical students about promotion, Richard Laing

[e-drug] Teaching pharmacy and medical students about promotion (2), Emmanuel Alphonce
- [e-drug] Teaching pharmacy and medical students about promotion(3), Stevan Gressitt

[e-drug] WHO workshop on IP rights and vaccines in developing countries, Miloud Kaddar

[e-drug] 18 Nov The Hague: Setting priorities, missing the point, Spring Gombe

[e-drug] Can we document experiences with PEPFAR please? (8), Albert Petersen

[e-drug] Vacancies for pharmacists in Tajikistan and in Cambodia, Martins

[e-drug] Global public private partnerships: new publication, PatientView

[e-drug] therapeutic equivalence of different dosage forms?, r ancuceanu

[e-drug] therapeutic equivalence of different dosage forms? (4), Murtada Sesay
[e-drug] therapeutic equivalence of different dosage forms? (5), Peter Mol
[e-drug] therapeutic equivalence of different dosage forms? (6), Rakesh Chaurasia

[e-drug] Electronic Prescribing, Mark Duman

[e-drug] Regulating health: global pharmaceuticals in transition, Ken Harvey

[e-drug] therapeutic equivalence of different dosage forms? (2), Nadeem Irfan Bukhari

[e-drug] promotion material produced by the industry, saeed farooq

[e-drug] therapeutic equivalence of different dosage forms? (3), romaci

[e-drug] shortage of artemisinin-based combination therapy for malaria, E-drug

[e-drug] Ranbaxy withdraws all generic ARVs from WHO Prequalification, E-drug

[e-drug] Ranbaxy withdraws all generic ARVs from WHO Prequalification (2), Warren Kaplan

[e-drug] IFPMA reorganising after criticism, E-drug

[e-drug] Race-based medicine, Andy Gray

[e-drug] How to detect misleading claims in clinical research reports, E-drug

[e-drug] shortage of ACT for malaria (2), Christine Sadia

[e-drug] Ranbaxy withdraws all generic ARVs from WHO Prequalification (2), E-drug

[e-drug] Ranbaxy withdraws all generic ARVs from WHO Prequalification(3), Francisco Rossi

[e-drug] shortage of ACT for malaria (3), Cheri Grace

[e-drug] Shortage of ACT for malaria (4), Sean . HEALY

[e-drug] unethical marketing of prescription drugs, Vera Hassner Sharav

[e-drug] WHO Expert Committee on Specifications for Pharmaceutical Preparations, E-Drug

[e-drug] WHO/AMDS Information Library, E-Drug

[e-drug] celecoxib warning in Turkey, F.CANKAT TULUNAY

[e-drug] DNDI: More resources needed for neglected diseases, Jaya Banerji

[e-drug] Shake-up for UK drug regulatory authority, Libby Levison

[e-drug] promotion material produced by the industry (2), Judith Mackson

[e-drug] Shortage of ACT for malaria (5), Judith Mandelbaum-Schmid

[e-drug] Qu4RAD conference: Are there alternatives to patents?, reinhard huss

[e-drug] shortage of ACTs and other pharmaceuticals, Libby Levison

[e-drug] shortage of ACTs and other pharmaceuticals (2), Murtada Sesay

[e-drug] NY Times: Do New Drugs Always Have to Cost So Much?, Nathan Ford

[e-drug] please be a little moderate...., Bernhard Edgren

[e-drug] please be a little moderate....(5), Chris W. Green

[e-drug] The concept of essential medicines: lessons for rich countries, E-Drug

[e-drug] Teaching pharmacy and medical students about promotion(4), Kevin Outterson

[e-drug] please be a little moderate.... (2), Valeria Frighi

[e-drug] please be a little moderate.... (4), Chandra Gulhati

[e-drug] shortage of ACTs and other pharmaceuticals (3), Abdelkrim Smine

[e-drug] BMJ on ARV rollout, Malawi experience, Wilbert Bannenberg

[e-drug] please be a little moderate.... (3), Sarah Sellers

[e-drug] Unaffordable drug prices cause hypertension non-compliance in Ghana, E-Drug

[e-drug] Unaffordable drug prices cause hypertension noncompliance (2), Murtada Sesay

[e-drug] therapeutic equivalence of different dosage forms? (7), claudia vacca

[e-drug] MSF: R&D System Failing to Meet Health Needs of Developing Countries, Rachel COHEN

[e-drug] Rofecoxib (Vioxx) withdrawal, Ciprian Jauca

[e-drug] Mexico Summit on Health Research -- press coverage, Sean Healey

[e-drug] proposed WHO EML changes 2005 (2), Cecile Godfroid

[e-drug] WHO Priority medicines report, E-Drug

[e-drug] Global Fund discusses procurement rules, Carmen Perez

[e-drug] Priority Medicines for Europe and the World (2), Christophe Kopp

[e-drug] Flu Vaccine, Warren Kaplan

[e-drug] Co-trimoxazole prophylaxis for all?, Ron Wehrens - Phasuma

[e-drug] Co-trimoxazole prophylaxis for all? (2), Eurek Ranjit

[e-drug] Global Fund Board Agrees to 5th Round of Proposals, Wilbert Bannenberg

[e-drug] Economist on ACT shortages, Nathan Ford

[e-drug] The important world of drug prequalification, Nathan Ford

[e-drug] Shortage of ACTs and other pharmaceuticals (4), Oliver Hazemba

[e-drug] The important world of drug prequalification (2), JBRusso

[e-drug] Hetero withdraws 6 ARVs from WHO PQ list, E-Drug

[e-drug] Insomnia treatments harmful and not effective, E-Drug

[e-drug] WHO's TB control strategy said to be insufficient, E-Drug

[e-drug] New vaccines to fight killer rotavirus, E-Drug

[e-drug] Priority Medicines for Europe and the World - conclusions, Wilbert Bannenberg

[e-drug] Free WHO Medicines Bookshelf CD-ROM, WHO/EDM Documentation Centre

[e-drug] Attending to a sick industry?, Wilbert Bannenberg

[e-drug] Attending to a sick industry? (2), Kibumba George

[e-drug] Regulating pharmaceuticals in Europe, Wilbert Bannenberg

[e-drug] RFI: Nimesulide ADRs?, Olutayo Adetokunbo

[e-drug] RFI: Nimesulide ADRs? (2), Rakesh Chaurasia
- [e-drug] RFI: Nimesulide ADRs? (4), Chandra Gulhati
  - [e-drug] RFI: Nimesulide ADRs? (7), rahmansz
  - [e-drug] RFI: Nimesulide ADRs? (8), Dr.L.Offerhaus
[e-drug] RFI: Nimesulide ADRs? (3), Chandra Gulhati
- [e-drug] RFI: Nimesulide ADRs? (5), Dr.Anupam Aggarwal
  - [e-drug] RFI: Nimesulide ADRs? (6), Dr P.H. Rao
  - [e-drug] RFI: Nimesulide ADRs? (9), Chandra Gulhati

[e-drug] Dorette Corbey (MEP) on R&D for neglected diseases, Wilbert Bannenberg

[e-drug] Revisiting phenobarbital for epilepsy, Wilbert Bannenberg

[e-drug] Wording of Papers, Use of Statistics, Kibumba George

[e-drug] Wording of Papers, Use of Statistics (2), Dr.Leo Offerhaus
[e-drug] Wording of Papers, Use of Statistics (3), Klara Tisocki

[e-drug] QU4RAD e-conference: are there alternatives to patents?, Amorie Glenn J. de Guzman

[e-drug] celebrex in Turkey, F.CANKAT TULUNAY

[e-drug] cotrimoxazole prophylaxis in children, Wilbert Bannenberg

[e-drug] Scaling up access to ARVs with African community based organizations, c . prunier

[e-drug] new professional search tool scholar.google.com, E-Drug

[e-drug] Postmarketing Surveillance - Lack of Vigilance, Lack of Trust, E-Drug

[e-drug] Revolving Drug Funds at village level, Bigdeli, Ms Maryam (LAO)

[e-drug] Pharmaceutical industry funding of clinical research, Joel Lexchin

[e-drug] Revolving Drug Funds at village level (2), tatah

[e-drug] Rofecoxib ADRs, pals

[e-drug] RFI: Nimesulide ADRs? (10), miriam

[e-drug] MSF: Guatemala Repeals Law That Restricted Access to Medicines, E-Drug

[e-drug] Europe's health priorities for the world, E-Drug

[e-drug] Vioxx, the implosion of Merck, and aftershocks at the FDA, E-Drug

[e-drug] Nimesulide (final), Olutayo Adetokunbo

[e-drug] Rescuing malaria treatment, or not?, E-Drug

[e-drug] Patent Legislation Analysis in Latin America / Caribbean, Gabriela Costa Chaves

[e-drug] Advanced Purchase Contracts and Other Ideas, Spring Gombe

[e-drug] two generic ARVs back on WHO Prequalification list, E-Drug

Mail converted by MHonArc 2.6.8